Form 4: Hinge Health CFO Sells Shares Under 10b5-1 Plan

Hinge Health's CFO, James Budge, sold 44,589 shares of Class A Common Stock on November 25, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• James Budge, Chief Financial Officer of Hinge Health, Inc. (HNGE), reported the sale of 44,589 shares of Class A Common Stock.
• The transactions occurred on November 25, 2025, and were executed pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2025.
• The shares were sold in three separate transactions at weighted average prices of $46.8822, $47.7669, and $48.2738.
• Following these sales, Mr. Budge directly beneficially owns 479,878 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The filing reports a pre-scheduled sale of shares by the CFO under a Rule 10b5-1 trading plan, which is a routine disclosure and does not inherently indicate a strong positive or negative sentiment about the company's immediate prospects.

Negatives

• Chief Financial Officer James Budge reduced his direct beneficial ownership in Hinge Health, Inc. by selling 44,589 shares of Class A Common Stock.

Stakeholder Impact

• Shareholders: The sale by a key executive, even under a pre-arranged plan, reduces insider ownership, which some investors may view as a slight negative, though it is a common practice for personal financial management.

Key Dates

Keywords

Hinge Health, HNGE, James Budge, CFO, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan